NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,188,318 | -18.7% | 139,849 | -10.6% | 0.01% | -8.3% |
| Q2 2023 | $7,609,791 | -21.4% | 156,387 | -10.3% | 0.01% | -25.0% |
| Q1 2023 | $9,677,080 | +301.4% | 174,299 | +190.4% | 0.02% | +300.0% |
| Q4 2022 | $2,410,682 | -54.2% | 60,012 | -50.1% | 0.00% | -55.6% |
| Q3 2022 | $5,268,000 | -41.3% | 120,213 | -52.6% | 0.01% | -40.0% |
| Q2 2022 | $8,980,000 | -73.3% | 253,394 | -69.3% | 0.02% | -65.9% |
| Q1 2022 | $33,580,000 | -51.3% | 825,459 | +11.8% | 0.04% | -46.3% |
| Q4 2021 | $68,953,000 | +16.9% | 738,331 | +39.5% | 0.08% | +13.9% |
| Q3 2021 | $58,963,000 | +24.7% | 529,101 | +27.0% | 0.07% | +28.6% |
| Q2 2021 | $47,284,000 | -10.3% | 416,490 | -21.4% | 0.06% | -12.5% |
| Q4 2020 | $52,740,000 | +33.6% | 529,941 | -3.0% | 0.06% | +14.3% |
| Q3 2020 | $39,482,000 | +78.9% | 546,533 | +23.5% | 0.06% | +60.0% |
| Q2 2020 | $22,071,000 | – | 442,650 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |